Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,25811,907,1.08 [0.89-1.30],0.4303542594672557
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,25832,145,1.65 [1.04-2.62],0.0348302106618373
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27435,155,0.99 [0.63-1.55],0.971021066261786
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,20516,504,1.29 [1.00-1.66],0.0464738375231965
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,27373,93,0.90 [0.51-1.60],0.7189631222365647
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,26644,80,2.50 [1.35-4.66],0.0037224394953494
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",28415,92,0.92 [0.52-1.64],0.777725035583333
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,28434,64,0.91 [0.46-1.81],0.7842962535569686
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,26078,46,4.03 [1.79-9.04],0.0007366959873467
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27893,110,2.32 [1.37-3.91],0.0016594154432733
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27852,69,3.11 [1.61-5.98],0.0007077468725921
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,28477,67,0.99 [0.50-1.95],0.9684219668647654
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,28437,99,1.57 [0.90-2.73],0.1125782564309006
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",28427,89,1.79 [1.00-3.20],0.0513356891437866
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,28237,44,0.71 [0.31-1.63],0.4243429648875174
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",27597,396,1.05 [0.79-1.39],0.7202990899099638
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,27350,149,1.49 [0.95-2.35],0.0858320317939605
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,27454,253,0.88 [0.62-1.25],0.4665471891913386
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",24720,30,0.28 [0.11-0.76],0.0117463375733046
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",24738,48,1.70 [0.75-3.83],0.2009304489925202
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",24819,129,0.74 [0.45-1.22],0.2340992794782384
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",24824,134,0.73 [0.45-1.19],0.2119704372617786
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",13890,294,0.84 [0.60-1.18],0.3122278941949103
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",11122,28,0.79 [0.28-2.27],0.6680754947558831
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",24739,49,2.43 [1.11-5.29],0.0256430708835166
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26312,829,0.99 [0.82-1.21],0.933597682590766
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27399,203,0.61 [0.41-0.90],0.0127453711771769
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,28056,80,0.82 [0.44-1.52],0.5248627909217722
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",28550,74,0.55 [0.29-1.04],0.0660412989264515
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,28312,48,0.60 [0.27-1.34],0.2147898954167191
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,28559,40,1.23 [0.51-2.98],0.6486662016972204
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Stomach,28599,33,0.87 [0.33-2.32],0.7854534882805669
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,28286,303,0.84 [0.61-1.16],0.2886638677414499
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,28528,119,0.81 [0.48-1.34],0.4067940993058534
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,28533,97,1.10 [0.63-1.93],0.7336960259180876
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",28498,45,0.71 [0.31-1.63],0.4203457600172994
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",28500,45,0.71 [0.31-1.63],0.4204958032925684
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,28389,250,0.82 [0.58-1.17],0.277150529182511
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,28558,112,0.72 [0.43-1.23],0.2303197445813941
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,28463,190,0.91 [0.61-1.37],0.6663941034718557
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of breast,15770,94,2.25 [1.26-4.05],0.0064612737531603
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,15399,703,0.94 [0.75-1.17],0.5854671876325828
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,27561,202,0.84 [0.57-1.25],0.3902061919017882
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,27445,356,0.89 [0.66-1.20],0.453898657694783
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,27445,356,0.89 [0.66-1.20],0.453898657694783
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26210,366,1.34 [1.00-1.80],0.052373288560084
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,28116,81,1.42 [0.77-2.63],0.2590613440969914
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,28329,107,2.15 [1.27-3.67],0.0047125059957667
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,25091,714,1.25 [1.01-1.55],0.039419953164138
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,27260,447,0.69 [0.53-0.90],0.0068945133048718
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,26753,117,9.55 [5.89-15.49],6.135229450446747e-20
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,27829,55,2.18 [1.05-4.54],0.0370809188280247
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,26739,103,,
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,26967,331,1.19 [0.87-1.63],0.2810789889573342
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26957,321,1.13 [0.82-1.56],0.4500991201121439
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26619,183,0.61 [0.39-0.95],0.0299679480517535
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26623,180,0.61 [0.38-0.96],0.0321999974484116
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24924,547,1.18 [0.92-1.51],0.1879869979140341
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",24453,76,0.83 [0.44-1.58],0.5795718308403579
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,24878,501,1.23 [0.95-1.59],0.1157859981754489
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,24421,44,2.90 [1.27-6.66],0.0117440559444771
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",24457,80,2.97 [1.61-5.48],0.0005198264218101
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,24825,773,0.71 [0.58-0.88],0.0012980868470409
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",24351,299,0.61 [0.44-0.86],0.0039433459624797
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",28155,230,0.63 [0.44-0.91],0.0137688405214728
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",28227,164,0.64 [0.41-0.98],0.0414784619380923
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,26581,84,0.60 [0.33-1.11],0.1029514279558066
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",28480,84,0.63 [0.35-1.16],0.1391568904816247
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",24136,84,0.59 [0.32-1.09],0.0932825968344341
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Alcohol dependence,26595,98,0.73 [0.42-1.29],0.2842913014007572
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,26561,68,0.73 [0.37-1.42],0.3543347839022864
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",24126,74,1.12 [0.59-2.14],0.7354225582869239
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24443,391,0.68 [0.51-0.90],0.0069798079283507
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression,26840,340,0.61 [0.45-0.82],0.0013362340504497
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression or dysthymia,24293,298,0.62 [0.45-0.86],0.0039251877598417
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24199,147,0.64 [0.41-1.01],0.057769255502958
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Other anxiety disorders,27065,70,0.70 [0.36-1.36],0.2917437775677477
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,25435,1465,0.75 [0.65-0.87],0.0001947928532504
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,23732,165,0.27 [0.17-0.41],3.062768649384063e-09
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,28392,134,0.22 [0.14-0.36],3.840649488619602e-10
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,27221,496,1.05 [0.82-1.35],0.6945217983054345
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,26896,171,1.02 [0.67-1.56],0.9311239042303888
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,26828,103,0.89 [0.51-1.54],0.681384024287373
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",28219,94,0.90 [0.51-1.60],0.7200800116390629
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,28098,40,0.85 [0.35-2.06],0.7133835843438043
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,26897,172,1.15 [0.75-1.77],0.5220972618971012
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,27973,134,1.29 [0.79-2.08],0.3085342949452745
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",27446,624,0.90 [0.72-1.13],0.3601896048509754
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",26963,141,1.07 [0.67-1.71],0.7797590666246295
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,27158,336,0.86 [0.64-1.17],0.3399376452930011
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,28375,86,0.26 [0.15-0.46],3.193764524189204e-06
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,28343,54,0.24 [0.12-0.49],7.845915021299921e-05
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,28158,127,0.88 [0.54-1.44],0.6091835523588421
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",28119,315,0.87 [0.64-1.20],0.4020586266727557
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,27974,170,1.08 [0.70-1.65],0.7398395562294017
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,27895,91,0.66 [0.37-1.19],0.1689439040946949
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,27908,104,0.99 [0.58-1.71],0.9809493730605726
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,27855,51,0.81 [0.37-1.76],0.5982748201578905
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,26845,65,1.21 [0.60-2.42],0.5926134358771482
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,26970,190,1.36 [0.91-2.04],0.1336243235336342
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27973,136,2.30 [1.44-3.68],0.0005244639880377
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,28343,25,,
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,1789,25,9.28 [3.54-24.36],6.018749048777749e-06
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",26579,25,,
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,28218,50,1.61 [0.74-3.52],0.2305158021719014
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,28196,28,1.92 [0.68-5.42],0.2171158832671346
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",28118,97,0.85 [0.48-1.49],0.5635210564563576
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,28170,100,1.01 [0.58-1.75],0.9785906179099184
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,28467,127,0.64 [0.39-1.05],0.0748640952607901
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,28061,90,1.07 [0.59-1.92],0.8267397267149181
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22382,1999,1.07 [0.94-1.23],0.3121832228247635
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,28270,41,1.09 [0.46-2.59],0.8458384129294177
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23456,1322,1.08 [0.91-1.27],0.3714980482810406
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,23480,1346,1.17 [0.99-1.38],0.0633933732033469
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,22184,50,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",27062,577,1.26 [1.00-1.59],0.0546732892852442
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,26841,356,1.16 [0.86-1.57],0.3205324807567475
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,27873,144,1.20 [0.76-1.90],0.4292121826360434
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27999,270,1.46 [1.04-2.05],0.0278614371135439
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",28488,61,3.09 [1.55-6.15],0.0013522540451944
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",26651,166,1.66 [1.08-2.56],0.0215617107956855
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26903,429,1.36 [1.04-1.79],0.0261065153774243
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,28072,82,0.88 [0.48-1.62],0.6856349909307599
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,28062,179,1.10 [0.72-1.66],0.6657924260387613
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,28054,64,1.25 [0.62-2.49],0.533245175225671
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,28055,65,1.22 [0.61-2.43],0.569141908450489
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",22195,61,1.25 [0.60-2.58],0.5528930606990238
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,25907,47,1.36 [0.60-3.08],0.4618774308667571
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,25935,75,1.31 [0.69-2.51],0.4065802777343685
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,19556,96,1.23 [0.68-2.22],0.4877265603937508
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,19654,194,0.99 [0.65-1.50],0.952960958594797
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,25902,42,0.66 [0.28-1.54],0.3345769692104758
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,25923,63,1.29 [0.64-2.62],0.4741924484347698
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",28082,122,1.38 [0.84-2.29],0.2064680278508286
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",28050,114,0.81 [0.49-1.37],0.4390490915309406
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",28084,85,0.75 [0.41-1.37],0.3530575968869046
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",28132,74,0.81 [0.42-1.53],0.5100290014904086
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,27853,52,1.08 [0.50-2.33],0.846436311908854
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,27885,84,1.41 [0.77-2.58],0.2595007734575916
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),27337,118,1.14 [0.68-1.90],0.6209855054710106
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,27316,97,1.35 [0.77-2.36],0.2998200526409786
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",28429,93,1.39 [0.78-2.46],0.2639479933620177
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,27662,443,0.72 [0.55-0.95],0.0177618051682039
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,27845,55,1.23 [0.58-2.60],0.5824471756327138
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,24207,1983,0.89 [0.78-1.02],0.0986809752195374
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,28371,139,0.67 [0.42-1.08],0.0991986358256604
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27367,192,0.96 [0.64-1.44],0.8525516718930853
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",27339,164,1.10 [0.71-1.70],0.6679006830228313
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27973,217,0.67 [0.46-0.97],0.0348921966343627
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27971,215,0.67 [0.46-0.98],0.0383017412387242
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,27696,679,1.27 [1.02-1.57],0.0319922017817348
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,27116,99,0.61 [0.35-1.06],0.0789276349849347
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,27126,109,1.78 [1.04-3.02],0.0342325322416913
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",27454,437,1.23 [0.94-1.61],0.1247267017662724
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,27253,236,1.65 [1.15-2.37],0.0063742249073842
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,16477,51,0.89 [0.40-1.95],0.7639008312088539
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26175,894,0.74 [0.61-0.90],0.0019259199751311
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,27871,109,0.64 [0.38-1.08],0.0967049834707818
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27871,109,0.64 [0.38-1.08],0.0967049834707818
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",27871,109,0.64 [0.38-1.08],0.0967049834707818
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",26784,811,0.70 [0.57-0.85],0.0004327719127552
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Asthma,21892,811,0.68 [0.56-0.84],0.0002500865893484
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21747,811,0.68 [0.56-0.84],0.000257367859148
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21876,795,0.68 [0.56-0.84],0.0002473702696995
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,28406,58,1.35 [0.66-2.78],0.4109861773920037
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,27256,44,1.43 [0.62-3.28],0.4009153521149478
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",28469,44,1.44 [0.63-3.28],0.3891206332978238
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,27249,37,0.98 [0.39-2.43],0.9616804262195816
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,27217,78,0.73 [0.39-1.37],0.3236553603791431
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,27321,182,0.77 [0.51-1.16],0.2060709664851762
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27734,85,0.82 [0.45-1.49],0.5044293410034419
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,20236,5234,0.86 [0.79-0.94],0.0012868557293341
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",27973,509,1.02 [0.80-1.31],0.874651622924505
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,28526,144,1.30 [0.82-2.07],0.2702350294281578
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,28532,134,1.31 [0.81-2.12],0.2778699809501731
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,27591,127,0.97 [0.59-1.58],0.893172676674426
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,27572,108,0.95 [0.56-1.63],0.8597772260955308
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,28510,160,1.20 [0.77-1.87],0.4141870889862518
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,27561,97,0.97 [0.55-1.70],0.9030858003361196
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,27299,65,1.17 [0.59-2.33],0.6516086777741168
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,28472,45,1.34 [0.59-3.05],0.4845352441089271
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,23000,206,0.56 [0.38-0.83],0.003451575374904
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24559,1765,0.80 [0.69-0.92],0.0013240110255161
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,23068,274,0.88 [0.63-1.23],0.4576066389185794
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23351,557,0.87 [0.68-1.10],0.2382385780337015
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,22859,65,0.80 [0.40-1.59],0.5229965901730476
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,22926,132,0.74 [0.45-1.20],0.2237649418303303
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,22825,31,2.20 [0.81-5.98],0.1214680054553542
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,22897,103,0.52 [0.30-0.89],0.017949264867862
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,22899,105,0.70 [0.40-1.20],0.1923647721076947
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",28492,74,0.66 [0.35-1.26],0.2105556377935749
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,22897,103,0.49 [0.29-0.85],0.0113731010804353
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),23439,645,0.76 [0.61-0.95],0.0147376109632531
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,28405,161,0.82 [0.53-1.27],0.3733320729608099
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,23181,387,0.93 [0.70-1.24],0.6437874061837352
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,22910,116,1.03 [0.61-1.74],0.9122467799731168
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,28395,189,1.37 [0.92-2.05],0.1211560688360748
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,28370,126,0.92 [0.56-1.52],0.7531146434133278
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,25773,1199,0.86 [0.73-1.01],0.0662976418979476
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,24980,406,1.50 [1.13-1.98],0.0043920703219907
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,24697,123,0.98 [0.60-1.62],0.9478396246573632
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,24669,95,0.91 [0.52-1.61],0.748753916899398
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25182,608,0.62 [0.49-0.78],4.68050197887657e-05
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,27690,761,1.15 [0.94-1.41],0.1745170429770209
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,23548,1690,0.86 [0.74-0.99],0.0317552858116674
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",28256,73,2.61 [1.37-4.96],0.0034603858133888
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",28514,104,2.37 [1.39-4.07],0.0016567810490831
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,27033,104,2.39 [1.39-4.12],0.0016738750863672
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,27008,79,2.64 [1.42-4.91],0.0021962291332992
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",28458,135,1.95 [1.22-3.14],0.0056845331297441
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,27064,135,1.97 [1.22-3.17],0.0056759184523001
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",27046,117,2.31 [1.38-3.86],0.0013581007148107
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,27534,605,0.93 [0.74-1.17],0.5437263022024992
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,27529,600,0.94 [0.75-1.18],0.5923832332291776
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,21931,73,0.75 [0.39-1.44],0.3824518554750181
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal stricture,28251,73,0.77 [0.40-1.47],0.4282845479492471
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",21908,50,0.81 [0.37-1.79],0.5998577655065154
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22163,305,0.78 [0.56-1.08],0.1389784379659428
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,22037,179,0.71 [0.47-1.08],0.1123481199043234
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,22116,258,0.78 [0.55-1.11],0.165410143408867
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,27402,231,0.91 [0.63-1.32],0.6296362776717239
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,28167,85,0.85 [0.46-1.55],0.5857357593232833
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,22036,178,1.42 [0.94-2.16],0.0975513320449335
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,21945,87,1.30 [0.72-2.37],0.3871351141778966
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,22658,800,0.76 [0.62-0.93],0.0084538765627071
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,22041,183,0.97 [0.64-1.47],0.8893608249193047
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,28154,72,0.52 [0.27-1.01],0.0535278561640483
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,27841,124,2.03 [1.24-3.31],0.0045573466422746
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,27782,65,1.82 [0.92-3.60],0.0856126636865376
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",27328,532,0.72 [0.56-0.91],0.0072123935372351
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,27214,418,0.68 [0.52-0.90],0.0060930260582618
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,26875,79,0.80 [0.43-1.50],0.4959183936037391
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,26843,47,0.86 [0.38-1.94],0.7159413852415664
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,26858,62,1.93 [0.96-3.87],0.0655907937063776
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),28422,62,1.96 [0.98-3.91],0.057912227244862
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,27301,289,0.76 [0.55-1.06],0.1049615525730958
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,27080,68,0.82 [0.42-1.62],0.5733626704675782
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,27065,53,0.78 [0.36-1.68],0.5201411199436055
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",27054,42,0.82 [0.35-1.94],0.6517913597810527
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,27198,186,0.71 [0.47-1.06],0.094268486823265
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,27193,181,0.70 [0.46-1.05],0.0833428408653355
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25942,1514,1.05 [0.91-1.22],0.5126969095647664
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,28207,102,0.83 [0.48-1.44],0.5084839113228947
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,28151,474,0.97 [0.75-1.25],0.7908335734880818
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,27466,544,1.18 [0.93-1.50],0.1848667435117678
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,27798,400,1.03 [0.78-1.37],0.8114869414237331
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",27503,105,1.30 [0.76-2.23],0.3378541655964057
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,27626,228,1.30 [0.90-1.89],0.1616327999317485
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,28341,87,1.27 [0.70-2.29],0.427721953230577
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,28327,73,1.19 [0.63-2.28],0.590582894184077
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,28306,52,1.27 [0.59-2.72],0.5378644970124522
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,28420,34,2.08 [0.80-5.39],0.1303739001782582
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,28417,31,2.00 [0.74-5.40],0.1716164428112732
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,27740,63,0.67 [0.33-1.34],0.255660321936646
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,28041,364,1.19 [0.89-1.59],0.2526538165224602
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,26994,72,0.80 [0.41-1.56],0.5166264484850186
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,27023,101,1.10 [0.63-1.92],0.7338450132378899
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,27007,85,0.74 [0.41-1.36],0.3355295359633855
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",27138,216,1.17 [0.80-1.71],0.4226643383891644
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,27109,187,1.24 [0.83-1.87],0.2935360181747025
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22148,3585,1.00 [0.90-1.11],0.975930903539346
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,23789,1894,1.10 [0.96-1.26],0.1571245767143538
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,26112,1129,1.01 [0.85-1.20],0.8895172109348063
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,22014,119,0.72 [0.43-1.20],0.2090106452001481
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,22240,345,0.89 [0.66-1.20],0.4473700555772356
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",28255,113,0.72 [0.43-1.21],0.2156379804847424
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,28272,101,0.70 [0.40-1.22],0.2067837034033025
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,22564,669,0.99 [0.79-1.23],0.9067456939219384
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",25200,669,0.99 [0.79-1.23],0.9317241938049864
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,21941,46,1.14 [0.50-2.61],0.7474627806398091
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",28201,45,1.28 [0.56-2.94],0.5558831954771055
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,22049,154,0.86 [0.55-1.34],0.5000584402067763
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,21920,25,0.72 [0.24-2.18],0.5658849417760914
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,22023,128,0.62 [0.38-1.01],0.0562850054726223
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",28481,63,0.57 [0.28-1.14],0.1091875836420161
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,22228,333,1.13 [0.83-1.54],0.452677930259511
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,22123,228,0.97 [0.67-1.41],0.8795235977644954
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,23158,1263,1.19 [1.01-1.39],0.0392007279977697
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),21932,37,1.12 [0.45-2.82],0.8075789224476899
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),22071,176,0.76 [0.49-1.15],0.1922583509687037
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,21931,36,1.28 [0.50-3.26],0.6015794123751887
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),21924,29,0.94 [0.33-2.68],0.9150692528621835
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,22429,534,1.56 [1.22-1.99],0.0003791860955934
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,22340,445,1.62 [1.24-2.12],0.0003947708020777
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,22644,286,1.11 [0.79-1.54],0.5516622183984595
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,28193,152,2.14 [1.37-3.32],0.0007510957979401
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,28082,41,1.96 [0.84-4.59],0.1196886886932398
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,25580,49,0.31 [0.14-0.68],0.0032571430252876
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,25753,222,0.82 [0.56-1.19],0.298533132401515
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26452,921,0.80 [0.67-0.97],0.0214316528489105
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,25669,138,0.64 [0.40-1.03],0.0674366135242142
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,25588,57,1.01 [0.49-2.11],0.9757051439042989
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",26306,775,0.84 [0.68-1.03],0.0901154432996437
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,25590,59,0.97 [0.47-2.00],0.9252394856891906
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,25786,255,0.94 [0.66-1.33],0.726198774620008
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,25647,116,1.15 [0.68-1.93],0.6054430986424411
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,25604,73,0.88 [0.46-1.69],0.6950066834689026
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,25683,152,0.60 [0.38-0.95],0.0290165361648467
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,25599,68,0.39 [0.20-0.77],0.006610726283808
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,25859,328,0.95 [0.70-1.30],0.7598576022319908
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,25276,293,0.97 [0.70-1.35],0.8755554829933719
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,25039,56,1.10 [0.52-2.33],0.7980380524576279
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,25039,56,1.21 [0.58-2.55],0.6108889167847861
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,25102,119,0.68 [0.41-1.14],0.1426308658789091
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",25041,58,0.85 [0.40-1.78],0.6678221253516382
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,25049,66,0.55 [0.28-1.08],0.0828881986331127
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],25033,50,0.57 [0.26-1.24],0.1563023957639131
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,25219,236,1.02 [0.71-1.47],0.9020113124861088
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,25036,53,0.99 [0.46-2.12],0.9711568520562548
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,25039,56,0.59 [0.28-1.25],0.1698328133979978
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,25097,114,0.86 [0.51-1.45],0.5695101890983241
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,25056,73,1.39 [0.72-2.67],0.3226883421229877
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",25416,433,1.02 [0.78-1.34],0.8755832172016409
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,25130,147,0.89 [0.56-1.41],0.6162403820867742
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,25207,224,1.23 [0.84-1.78],0.2867191812965589
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,27187,102,0.93 [0.54-1.61],0.8040704710357695
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,27430,345,1.01 [0.75-1.36],0.940835586557676
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,27142,57,0.91 [0.43-1.89],0.7925130328907459
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,27154,69,1.00 [0.51-1.95],0.9923637958160348
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,27201,116,1.44 [0.86-2.42],0.1640216870639652
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,24180,4471,0.75 [0.68-0.82],1.197518541938036e-09
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,11613,418,1.05 [0.80-1.39],0.7234306690322223
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27030,211,9.40 [6.51-13.58],7.401621208896277e-33
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,26874,55,3.60 [1.70-7.64],0.0008362140669973
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,27186,45,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,27189,48,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,27196,55,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,28209,244,1.35 [0.95-1.93],0.0957307878525308
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,28285,53,4.83 [2.30-10.15],3.159964465959487e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,28135,170,1.29 [0.84-1.97],0.2392617974237353
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,28061,96,1.29 [0.74-2.26],0.3744415033540441
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,27045,895,0.90 [0.74-1.09],0.2681845185187351
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,26234,84,1.08 [0.59-1.98],0.8108916955148655
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,26216,66,0.97 [0.49-1.93],0.9329031538803436
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,26334,184,1.27 [0.84-1.91],0.2502417847589407
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,26237,87,1.61 [0.89-2.91],0.1180220117023962
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,26781,631,0.78 [0.63-0.98],0.0343545377087497
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,11268,73,0.67 [0.35-1.28],0.2255766821405425
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),11231,36,2.87 [1.16-7.09],0.0224265237182751
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,11234,39,1.42 [0.59-3.43],0.4386321961327499
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",11288,93,1.43 [0.80-2.55],0.2261754225048508
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,11261,66,0.54 [0.27-1.08],0.080459113113392
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,11300,105,1.42 [0.83-2.44],0.2057232711327374
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,15618,253,1.15 [0.80-1.65],0.4553098367837573
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,15437,72,1.50 [0.76-2.93],0.24026521775109
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,15455,90,1.13 [0.62-2.08],0.6933885113804268
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,15421,56,1.47 [0.68-3.14],0.3249176067488776
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,15578,401,1.08 [0.81-1.44],0.6198601789110226
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,15261,84,1.11 [0.59-2.08],0.750569492417184
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,15374,197,0.96 [0.63-1.44],0.8293268870942112
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,14367,2819,0.80 [0.71-0.90],0.0002379748041005
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,11850,302,0.63 [0.45-0.88],0.0063988229377306
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,11639,91,0.95 [0.52-1.73],0.8628245221528317
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),11666,118,0.41 [0.24-0.69],0.000845531237104
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,11860,312,0.53 [0.38-0.74],0.000154653194373
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,11857,309,0.76 [0.54-1.05],0.0981462066669247
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,12034,486,0.78 [0.60-1.02],0.0658966286960456
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,11718,170,0.76 [0.49-1.18],0.2178691256221212
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",11769,221,0.55 [0.37-0.81],0.0023088390376601
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,11633,85,0.98 [0.52-1.83],0.9381530805120324
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,11690,142,1.41 [0.87-2.28],0.1638970534724517
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",15771,205,1.35 [0.90-2.02],0.1452425154222232
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,15781,196,1.34 [0.89-2.03],0.1631709817735688
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,15801,113,1.58 [0.92-2.72],0.0970643401618041
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",15792,123,1.52 [0.90-2.55],0.1157269948257397
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,11622,74,0.86 [0.44-1.67],0.6577149854726182
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,11610,62,0.56 [0.27-1.15],0.1142805961850964
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,11625,77,0.88 [0.46-1.70],0.7053357049403013
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,15694,384,0.85 [0.63-1.14],0.2845289509968695
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",12711,1163,0.71 [0.59-0.85],0.0001276895420297
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,12342,794,0.65 [0.53-0.80],5.6389251362481256e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",15780,160,1.16 [0.73-1.82],0.5329189397280878
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,11909,361,0.77 [0.56-1.04],0.0876677987975558
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,11830,282,0.80 [0.56-1.12],0.1915181202325445
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,11815,267,0.87 [0.61-1.24],0.4386912483595904
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female infertility,11665,117,1.01 [0.59-1.74],0.9686627457230222
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",11658,110,1.02 [0.58-1.79],0.9453138088176964
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,15795,890,0.84 [0.68-1.05],0.1255960977988295
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,15802,1214,0.74 [0.61-0.90],0.0021341881330174
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,15797,483,0.63 [0.47-0.82],0.0008827023706309
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,15452,138,0.65 [0.39-1.07],0.0902336748582372
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,15506,192,0.63 [0.41-0.97],0.0357050074723296
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,15481,167,0.50 [0.32-0.79],0.0028472276789158
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",15815,166,0.95 [0.60-1.51],0.8417668460532564
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,15817,163,0.98 [0.62-1.56],0.9400266502711084
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,15812,423,0.68 [0.51-0.92],0.0123595526544008
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,15515,126,0.86 [0.51-1.46],0.5847023770580677
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,15623,234,0.67 [0.45-1.00],0.0476067980741463
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,15055,150,0.50 [0.30-0.81],0.0053723611584708
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,15108,203,0.85 [0.56-1.30],0.4551648328792214
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,15160,255,0.82 [0.56-1.20],0.2981025507764988
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,15056,151,0.90 [0.55-1.46],0.6584821320051202
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,15044,139,0.83 [0.50-1.38],0.4827119535370392
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,15058,153,0.60 [0.37-0.97],0.0384321749468268
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,14822,234,0.79 [0.53-1.17],0.2385596760031358
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],15029,441,0.78 [0.58-1.04],0.0947231728813233
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,15268,680,0.74 [0.57-0.95],0.017139323307223
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",15818,173,0.63 [0.40-1.00],0.0478893325850083
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,14343,132,0.66 [0.39-1.11],0.1175975722429017
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",14693,105,0.79 [0.44-1.42],0.4230991611173724
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,15825,349,0.78 [0.56-1.07],0.1272241052273331
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,15742,266,0.76 [0.52-1.10],0.1431255095699425
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",15813,257,0.89 [0.61-1.30],0.543400844701722
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",15803,247,0.87 [0.59-1.27],0.4723719888919425
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",28342,36,0.32 [0.13-0.78],0.0120208485913881
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26910,537,0.65 [0.51-0.83],0.0004796549395115
